Non-compressible hemorrhage is an unmet clinical challenge, which occurs in inaccessible
sites in the body where compression cannot be applied to stop bleeding. Current treatments …

Hemostatic biomaterials show great promise in wound control for the treatment of
uncontrolled bleeding associated with damaged tissues, traumatic wounds, and surgical …

Bleeding complications arising from trauma, surgery, and as congenital, disease‐
associated, or drug‐induced blood disorders can cause significant morbidities and …

Uncontrolled bleeding remains as a leading cause of death in surgical, traumatic, and
emergency situations. Management of the hemorrhage and development of hemostatic …

Most injuries are accompanied by acute bleeding. Hemostasis is necessary to relieve pain
and reduce mortality in these accidents. In recent years, the traditional hemostatic materials …

Hemorrhage is the leading cause of trauma-related deaths, in hospital and prehospital
settings. Hemostasis is a complex mechanism that involves a cascade of clotting factors and …

Wide interest in new hemostatic approaches has stemmed from unmet needs in the hospital
and on the battlefield. Many current commercial hemostatic agents fail to fulfill the design …

An uncontrolled hemorrhage can easily lead to death during surgery and military operations.
Despite the significant advances in hemostatic research, there is still an urgent and …

Traumatic hemorrhage can be a fatal event, particularly when large quantities of blood are
lost in a short period of time. Therefore, hemostasis has become a crucial part of emergency …

Medical science has witnessed significant progress in the development of hemostatic
materials, which save lives by supporting natural hemostatic ability. However, for the …